Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission (Q44643774)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 1, 2003

Language	Label	Description	Also known as
English	Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission	scientific article published on November 1, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0090-8258(03)00474-8

https://api.crossref.org/works/10.1016/S0090-8258(03)00474-8

28 March 2024

4

object named as

Xavier Fritel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599864

28 March 2024

author name string

Christophe Tournigand

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Christophe Louvet

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jean-Luc Molitor

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nidal Dehni

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Alain Sezeur

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Alain Pigné

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jean Cady

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jacques Milliez

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Aimery de Gramont

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0090825803004748?httpAccept=text/xml

1 reference

10.1016/S0090-8258(03)00474-8

https://api.crossref.org/works/10.1016/S0090-8258(03)00474-8

28 March 2024

https://api.elsevier.com/content/article/PII:S0090825803004748?httpAccept=text/plain

1 reference

10.1016/S0090-8258(03)00474-8

https://api.crossref.org/works/10.1016/S0090-8258(03)00474-8

28 March 2024

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

341-345

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal chemotherapy in the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival with intraperitoneal cisplatin in advanced ovarian cancer after second-look laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900474-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-8258(03)00474-8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44643774&oldid=2113449385"